Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01926873 · ClinicalTrials.gov registry record
A Screening Study To Assess The Cognition Status in Healthy Volunteers
A clinical trial of Healthy Volunteer, sponsored by Hoffmann-La Roche.
- Completed
- Registry status
- 240
- Enrollment target
- 12
- Study locations
NCT01926873: Completed study of Healthy Volunteer, sponsored by Hoffmann-La Roche.
NCT01926873 is a study of Healthy Volunteer that has completed, run by Hoffmann-La Roche. The registered enrollment target is 240 participants, above the 200-participant average among 112 other Healthy Volunteer trials with a reported enrollment target (20% higher). The trial reports 12 study locations across 6 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01926873, a study of Healthy Volunteer, has completed, sponsored by Hoffmann-La Roche.
- COMPLETED
- Registry status
- 240 participants
- Enrollment target
- 12
- Study locations
Study Summary
This multi-center screening study will conduct a cognition assessment to collect reference data for comparison to patients with depression in healthy volunteers. Data will be collected for 6 weeks.
Conditions Studied
Study Locations (12)
Other
- - Freiburg im Breisgau
- - Mainz
- - Mannheim
- - Schwerin, Mecklenburg-Vorpommern
- - Bialystok
- - Choroszcz
- - Tuszyn
California
- - San Diego
Georgia
- - Atlanta
Illinois
- - Oak Brook
New York
- - Cedarhurst
Utah
- - Salt Lake City
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 240 participants |
| Start Date | 2013-08 |
| Est. Completion | 2014-07 |
What the finished NCT01926873 record still lists
NCT01926873 is an observational study that tracks outcomes without assigning an intervention. The registered 240 participants enrollment target is mid-sized for trials with a published cap, above the 200-participant average among 112 other Healthy Volunteer trials with a reported enrollment target (20% higher).
The record links to 1 condition, with Healthy Volunteer appearing as the primary indexed condition, and to 0 interventions.
NCT01926873 lists 12 locations in 6 states (Other, California, Georgia).
Frequently Asked Questions
What is clinical trial NCT01926873 about?
NCT01926873 is a clinical study titled "A Screening Study To Assess The Cognition Status in Healthy Volunteers". This multi-center screening study will conduct a cognition assessment to collect reference data for comparison to patients with depression in healthy volunteers. Data will be collected for 6 weeks.
What is the current status of trial NCT01926873?
This trial is currently completed. The enrollment target is 240 participants. The study started on 2013-08. Estimated completion is 2014-07.
What conditions does trial NCT01926873 study?
This clinical trial studies the following conditions: Healthy Volunteer.
Who is sponsoring clinical trial NCT01926873?
This trial is sponsored by Hoffmann-La Roche, which has 909 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01926873 being conducted?
This trial has 12 study locations across California, Georgia, Illinois, New York, Utah. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Healthy Volunteer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT01926873's enrollment target sits among peer trials
240 13th of 112 higher than 100 of 112 other Healthy Volunteer trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Healthy Volunteer trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Healthy Volunteer Study
RECRUITING · Phase 1
-
Neuropharmacologic Imaging and Biomarker Assessments of Response to Acute and Repeated-Dosed Ketamine Infusions in Major Depressive Disorder
RECRUITING · Phase 1
-
Phosphatidylethanol and Other Ethanol Consumption Markers
RECRUITING · NA
-
Role of Metal Ion Transporter ZIP8 in Alcohol-Related Behaviors
RECRUITING · Phase 1
-
A First-in-Human Single and Multiple Ascending Dose Study of MT-201
RECRUITING · Phase 1
-
Endogenous Oxalate Synthesis in Idiopathic Calcium Oxalate Kidney Stone Disease
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02855554 · 240 participants · NA
Quantitative Cardiac Parametric Mapping
- NCT03230565 · 240 participants · Phase 4
Continuous Infusions vs Scheduled Bolus Infusions
- NCT03399929 · 240 participants
Traumatic Brain Injury and Stroke Long Term Outcome
- NCT03583710 · 240 participants · Phase 3
Mitotane With or Without Cisplatin and Etoposide After Surgery in Treating Patients With Stage I-III Adrenocortical Cancer With High Risk of Recurrence
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia